• MPS Pharmaa Limited's board will meet on May 28, 2026, to approve audited financial results for Q4 and FY ended March 31, 2026.
• The board will also consider appointing M/s Sanghi & Co. as internal auditor for FY 2026-27.
• The company's trading window is closed for insiders until May 30, 2026, due to the results announcement.